Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Spero Therapeutics, Inc. (SPRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2023 |
4
| Shukla Sath (CEO and President) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 266,000 shares
@ $0 |
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Keutzer Timothy (COO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 265,957 shares
@ $0
Sold 3,394 shares
@ $1.86, valued at
$6.3k
|
|
| 02/03/2023 |
4
| JOSEPH TAMARA L (Chief Legal Officer) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 265,957 shares
@ $0
Sold 3,394 shares
@ $1.86, valued at
$6.3k
|
|
| 02/03/2023 |
4
| Shukla Sath (CFO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 265,957 shares
@ $0
Sold 9,504 shares
@ $1.8279, valued at
$17.4k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Tregoning Kathleen (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 30,943 options to buy
@ $1.74, valued at
$53.8k
|
|
| 01/05/2023 |
4
| VINK PATRICK V.J.J. (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,471 options to buy
@ $1.74, valued at
$26.9k
|
|
| 09/26/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 1,335,512 shares
@ $2.2503, valued at
$3M
Sold 566,284 shares
@ $2.2503, valued at
$1.3M
|
|
| 09/19/2022 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| Deshpande Milind (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| Pottage John C Jr (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| THOMAS FRANK E (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| Tregoning Kathleen (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/19/2022 |
4
| VINK PATRICK V.J.J. (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 09/14/2022 |
4
| HAMED KAMAL (Chief Medical Officer) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 210,000 shares
@ $0 |
|
| 08/30/2022 |
4
| Shukla Sath (CFO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Sold 6,017 shares
@ $0.8938, valued at
$5.4k
|
|
| 04/28/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 39,727 shares
@ $5.235, valued at
$208k
|
|
| 03/31/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 33,115 shares
@ $8.7884, valued at
$291k
Bought 16,885 shares
@ $8.7884, valued at
$148.4k
|
|
| 03/16/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 15,702 shares
@ $7.626, valued at
$119.7k
Bought 8,006 shares
@ $7.626, valued at
$61.1k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Aquilo Capital Management, LLC (10% Owner) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Bought 14,828 shares
@ $9.2419, valued at
$137k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Shukla Sath (CFO) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 38,014 shares
@ $0
Granted 53,190 options to buy
@ $11.18, valued at
$594.7k
|
|
|
|
|